CARCINOMA IN SITU OF BLADDER

Clinical trials for CARCINOMA IN SITU OF BLADDER explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA IN SITU OF BLADDER trials appear

Sign up with your email to follow new studies for CARCINOMA IN SITU OF BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Completed 1

New bladder cancer drug tested for safety in early trial

Disease control Completed

This early-stage study tested the safety of a new drug called UGN-301 for people with recurring non-muscle invasive bladder cancer. The drug was delivered directly into the bladder, both by itself and combined with other treatments. The main goal was to find a safe dose and under…

Matched conditions: CARCINOMA IN SITU OF BLADDER

Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

CARCINOMA IN SITU OF BLADDER

Get alerted when new CARCINOMA IN SITU OF BLADDER trials appear

New bladder cancer drug tested for safety in early trial